Acadian Asset Management’s Rallybio RLYB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,433
Closed -$92K 2202
2026
Q1
$92K Sell
10,433
-2
-0% -$14 ﹤0.01% 1769
2025
Q4
$56K Sell
10,435
-846
-7% -$4.35K ﹤0.01% 1777
2025
Q3
$44K Hold
11,281
﹤0.01% 1657
2025
Q2
$29K Hold
11,281
﹤0.01% 1545
2025
Q1
$57K Hold
11,281
﹤0.01% 1423
2024
Q4
$86K Hold
11,281
﹤0.01% 1388
2024
Q3
$104K Buy
11,281
+2,819
+33% +$27.2K ﹤0.01% 1583
2024
Q2
$89K Buy
8,462
+4,550
+116% +$61.7K ﹤0.01% 1547
2024
Q1
$57K Buy
+3,912
New +$54.5K ﹤0.01% 1364
2022
Q3
Sell
-1,274
Closed -$77K 1818
2022
Q2
$77K Buy
+1,274
New +$95.7K ﹤0.01% 1409

Other funds holding RLYB

Acadian Asset Management's RLYB Position: Q2 2026 in Review

Acadian Asset Management sold out of Rallybio (RLYB) in Q2 2026, closing a stake of 10,433 shares — an estimated $92K sold.

Acadian Asset Management first reported a position in RLYB in Q2 2022 and held it in 10 quarters. The position peaked at $104K in Q3 2024. 24 funds tracked by Wall St. Rank hold RLYB as of Q2 2026.

  • Acadian Asset Management reported no remaining Rallybio position as of Q2 2026 after selling out during the quarter.
  • Acadian Asset Management sold 10,433 Rallybio shares in Q2 2026, an estimated $92K.
  • Acadian Asset Management first reported a position in Rallybio in Q2 2022 and held it in 10 quarters.
  • Acadian Asset Management's Rallybio position peaked at $104K in Q3 2024.
  • 24 funds tracked by Wall St. Rank held Rallybio as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.